Signant Health, an enabler of evidence generation for modern clinical trials, agreed to acquire VirTrial, a provider of software solutions for remote site startup and decentralized clinical trial conduct. Financial terms were not disclosed. "VirTrial's mission is to ensure sites have the modern technology and tools they need to advance clinical research while the industry shifts toward more virtual visits and trial designs. With this announcement we are able to support our customers and their sites better than ever before by leveraging Signant Health's deep therapeutic and scientific experience, global reach, and operations scalability – and by providing direct access to complementary solutions for eCOA, eConsent, IRT, and more. As a Signant Health company, VirTrial could not be more excited and optimistic about the future of clinical research and the ability of sites to succeed," Mark Hanley, VirTrial President and CEO.